Fennec Pharmaceuticals
Price & Volume
Stats
See more52W Range | $4.68-$9.92 |
Market Cap | $294M |
Shares Short | 811,612 |
Financials
See moreRevenue (12 Mos) | $38.7M |
Revenue Growth (YoY) | 78.7% |
Gross Profit (12 Mos) | $36.1M |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 8 days ago
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
Yahoo Finance • 3 months ago
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
Yahoo Finance • 3 months ago
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 3 months ago
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
About
CEO | Mr. Jeffrey S. Hackman |
Address | 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
